The recently developed implantable variable-focus lenses, which enable people to see objects at varying distances by shifting their eyes slightly, are currently FDA-approved only for patients undergoing cataract surgery. But some ophthalmologists are also implanting them into the eyes of people without cataracts in order to correct presbyopia. This requires removing the eyes’ natural lenses, as is done in cataract surgery.

The Aging Eye: Preventing and Treating Eye Disease urges consumers to keep two things in mind before undergoing this surgery for presbyopia. First, it will not be covered by insurance unless you also have cataracts, and the cost can be $5,000 or more for each eye. Second, many ophthalmologists are reluctant to perform this procedure in people without cataracts because of the risks involved in any eye operation, as well as lack of information about long-term safety and effectiveness.

Risks of the operation include a very small chance of infection that may lead to blindness. It’s also important to understand that this surgery will not produce clear 20/20 vision.

The Aging Eye: Preventing and Treating Eye Disease discusses all the options for treating presbyopia and other common conditions affecting people as they grow older. This 48-page report, edited by Laura Fine, M.D., and Jeffrey Heier, M.D., both clinical instructors in ophthalmology at Harvard, also covers:

new medications for macular degeneration

treating glaucoma

preventing diabetic retinopathy

dealing with watery eyes, dry eyes, and other age-related problems.

The Aging Eye: Preventing and Treating Eye Disease is available for $16 from Harvard Health Publications, the publishing division of Harvard Medical School. Order it online at www.health.harvard.edu/CS or by calling 1-877–649–9457 (toll free).

© 2006 HealthNewsDigest.com